Biotech | August 01, 2025
Fermenta receives CEP by EDQM for Vitadee 100 SD
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
The company received one observation in the Form-483
Upgrades 2025 full-year CDMO sales and margin outlook
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
Subscribe To Our Newsletter & Stay Updated
